News & Perspective

Mar 18, 2013

Mar 18, 2013

Mold findings spark NJ compounding pharmacy recall

(CIDRAP News) – A New Jersey compounding pharmacy yesterday recalled all of its products after a Connecticut hospital found particulates in the company's magnesium sulfate intravenous (IV) solution that were confirmed to be mold.

Dec 20, 2012

Dec 20, 2012

Attack rate in fungal meningitis outbreak estimated at 4.4%

(CIDRAP News) – Researchers estimate from preliminary data that 4.4% of patients who were exposed to contaminated steroid drugs from a Massachusetts compounding pharmacy contracted fungal meningitis or other fungal infections, according to a new report in the New England Journal of Medicine.

Nov 15, 2012

Nov 15, 2012

Senate committee raises more meningitis outbreak questions

(CIDRAP News) – A Senate committee hearing today on the fungal meningitis outbreak covered some of the same ground as yesterday's House hearing but aired the views of compounding pharmacy industry groups and provided a strong example for strengthening the nation's public health infrastructure.

Nov 14, 2012

Nov 14, 2012

House committee grills FDA over fungal meningitis outbreak

(CIDRAP News) – The first congressional hearing today on the fungal meningitis outbreak linked to tainted steroids was marked by tough questions for regulators, political wrangling, and an appearance by the owner of the compounding pharmacy that produced the drugs, but he declined to testify.

Pages

by Topic

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»